Table 5.
Comparison of inflammatory factor levels between the two groups
| Parameters | Observation group (N=57) | Control group (N=57) | t value | P value | |
|---|---|---|---|---|---|
| COX-2 | Before treatment | 72.19±4.28 | 72.03±4.81 | 0.187 | 0.852 |
| After treatment | 29.31±5.09* | 38.17±5.28* | 9.121 | <0.001 | |
| IL-6 | Before treatment | 44.01±3.01 | 44.28±3.87 | 0.416 | 0.678 |
| After treatment | 15.29±2.91* | 21.37±2.70* | 11.563 | <0.001 | |
| TNF-α | Before treatment | 18.69±3.14 | 18.29±3.09 | 0.686 | 0.494 |
| After treatment | 5.18±0.92* | 9.47±1.04* | 23.326 | <0.001 | |
| 5-HT | Before treatment | 209.31±19.34 | 208.98±20.16 | 0.089 | 0.929 |
| After treatment | 131.89±16.28* | 163.29±18.31* | 9.676 | <0.001 | |
Note: COX-2: Cyclooxygenase-2; IL-6: Interleukin-6; TNF-α: Tumor necrosis factor-α; 5’-HT: 5-hydroxyptrytamine; Compared with those before treatment in the same group;
*
P<0.001.